Vimta Labs Ltd has added 58.88% over last one month compared to 9.74% gain in S&P BSE Healthcare index and 0.29% rise in the SENSEX
Vimta Labs Ltd lost 7.38% today to trade at Rs 243.4. The S&P BSE Healthcare index is down 0.01% to quote at 23317.99. The index is up 9.74 % over last one month. Among the other constituents of the index, Panacea Biotec Ltd decreased 4.99% and Hikal Ltd lost 3.12% on the day. The S&P BSE Healthcare index went up 51.21 % over last one year compared to the 53.67% surge in benchmark SENSEX.
Vimta Labs Ltd has added 58.88% over last one month compared to 9.74% gain in S&P BSE Healthcare index and 0.29% rise in the SENSEX. On the BSE, 51017 shares were traded in the counter so far compared with average daily volumes of 63140 shares in the past one month. The stock hit a record high of Rs 304 on 28 Apr 2021. The stock hit a 52-week low of Rs 65.5 on 20 May 2020.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.